Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Baltimore Rh Typing Laboratory was a pioneering non-profit medical institution founded in 1945 by Dr. Milton S. Sacks in Baltimore, Maryland. It was established as one of the first specialized facilities in the United States dedicated to the study of the Rh factor and the clinical management of hemolytic disease of the newborn (HDN). The laboratory provided essential diagnostic services, including prenatal blood typing and antibody titration, and was a major producer of standardized Rh typing reagents. Its extensive clinical research and data collection were instrumental in the development of Rh immune globulin (RhoGAM), which revolutionized neonatal care by preventing Rh sensitization. Although it is no longer active, the laboratory remains a significant entity in the history of hematology and transfusion medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baltimore Rh Typing Laboratory.